---

🐾 CANINE DISTEMPER VIRUS (CDV) — Complete Veterinary Guide

Sources: Merck Veterinary Manual, Veterian Key (Greene's Infectious Diseases of the Dog and Cat), Cornell University College of Veterinary Medicine, AAHA Canine Vaccination Guidelines 2022, MSD Veterinary Manual, PubMed peer-reviewed reviews (2024), Mass.gov Wildlife Disease Bulletin, WSAVA 2018 CDV Congress Paper.

---

SECTION 1: CLASSIFICATION & TAXONOMY

---

SECTION 2: VIRAL STRUCTURE — 6 Structural Proteins

---

SECTION 3: PHYSICAL & CHEMICAL PROPERTIES (Stability)

• CDV is a fragile virus — relatively unstable outside the host
• Sensitive to: lipid solvents (ether, chloroform), most disinfectants (phenols, quaternary ammonium compounds, bleach)
• Inactivated by: heat (56°C for 30 minutes), UV light, drying
• Survives in cold environments — most cases occur in fall and winter in dogs
• At room temperature (20°C): survives a few hours to 3 days in the environment
• At freezing temperatures: can survive weeks to months

---

SECTION 4: EPIDEMIOLOGY

4.1 Host Range (Very Broad)

Domestic cats can be infected experimentally but rarely show clinical disease. Domestic ferrets are extremely susceptible — nearly 100% mortality.

4.2 Distribution

4.3 Mortality Rates

• Adult dogs: ~50% mortality
• Puppies: ~80% mortality
• Ferrets and mustelids: ~100% mortality
• Wild carnivores (lions, etc.): can cause population-level epidemics

4.4 Age and Risk Groups

• Most susceptible: Unvaccinated puppies aged 3–6 months (when maternal antibodies wane)
• Also at risk: Unvaccinated adult dogs of any age
• Lower risk: Vaccinated dogs, older dogs with natural immunity
• Seasonal peak: Fall and winter in temperate climates

---

SECTION 5: TRANSMISSION

Primary Route: Aerosol / Respiratory Droplets

• Infected dogs shed CDV in nasal discharge, eye secretions, saliva, urine, feces
• Aerosol droplets from coughing, sneezing, or barking are the main route
• Direct contact with infected animals or contaminated fomites (bowls, bedding, hands)

Shedding Duration

• CDV shedding begins at ~7 days post-infection (even before clinical signs)
• Can shed for 60–90 days after recovery
• Some dogs shed virus for several months — important for shelter/kennel biosecurity

NO vertical transmission (mother to fetus) is well-documented in dogs, but transplacental infection causing abortion and weak puppies has been reported.

---

SECTION 6: PATHOGENESIS — Step by Step (The Most Important Section)

Stage 1 — Entry (Day 0–2)

• CDV enters via the respiratory tract — inhaled as aerosol
• The virus first infects lymphoid tissue in the upper respiratory tract — specifically the tonsils and retropharyngeal lymph nodes
• Primary viral replication begins here within 24 hours

Stage 2 — Primary Viremia (Day 2–4)

• Virus travels from tonsils in macrophages (monocyte-associated viremia) through lymphatics to the heart and then enters the bloodstream
• Spreads to spleen, thymus, bone marrow, lymph nodes, and other lymphoid tissue
• Replication in lymphoid organs causes lymphopenia — destruction of lymphocytes is a hallmark
• First fever spike occurs at this stage (Day 3–6)
• At this point, the dog may appear mildly ill or show only a brief low-grade fever

Stage 3 — Critical Immunological Decision Point (Day 8–14)

• Virus is cleared from most tissues
• Dog recovers, may never show serious signs
• No CNS or epithelial spread

• Virus escapes from lymphoid tissue and spreads further
• Proceeds to secondary viremia and epithelial/CNS invasion

Stage 4 — Secondary Viremia & Systemic Spread (Day 8–9+)

• Virus spreads hematogenously (through blood) as both cell-associated and plasma-phase viremia
• Infects epithelial cells of:
  • Respiratory tract
  • Gastrointestinal tract
  • Urinary/reproductive tract
  • Skin
• This causes the classic multi-system clinical signs (respiratory, GI, ocular)
• Virus shedding from all body secretions begins at this point — even in subclinical dogs

Stage 5 — CNS Invasion (Variable: Day 10 onward, or weeks to months later)

1. Hematogenous route — through blood via the choroid plexus
2. Neurotropic route — via olfactory nerves

• Infects oligodendrocytes (cells that make myelin) → causes demyelination
  • Week 1 post-infection: metabolic changes in oligodendrocytes
  • Week 2–3: morphological changes — stumped processes, cytoplasmic swelling
  • Myelin maintenance fails → progressive demyelination
• Infects neurons, astrocytes, and microglia → encephalitis
• Causes inclusion bodies in neurons and glial cells (see Histopathology section)
• Results in demyelinating leukoencephalitis (DL) — similar to multiple sclerosis in humans

Stage 6 — Old Dog Encephalitis (Rare, Chronic)

• CDV can persist in the CNS as a latent/slow infection for months to years
• Progressive, non-suppurative encephalitis develops
• Occurs in adult dogs — sometimes with no prior history of acute distemper
• Different from acute distemper CNS — characterized by vasculitis + perivascular cuffing

---

SECTION 7: CLINICAL SIGNS — By System

Phase 1 — Early Signs (Days 3–7 post-infection)

• Fever (biphasic) — first spike at Day 3–6, subsides, returns in 1–2 weeks
• Leukopenia (especially lymphopenia)
• Anorexia / lethargy
• These signs may go unnoticed

Phase 2 — Catarrhal Phase (Days 7–14+)

• Serous (watery) → mucopurulent (thick green) ocular discharge
• Conjunctivitis
• Keratoconjunctivitis sicca (dry eye) — CDV destroys lacrimal gland cells
• Corneal ulcers (in severe cases)

• Serous → mucopurulent nasal discharge
• Sneezing
• Cough
• Bronchopneumonia (secondary bacterial infection is common)
• Labored breathing in severe cases

• Vomiting
• Diarrhea (may be bloody in severe cases)
• Anorexia / weight loss

Phase 3 — Neurological Phase (Weeks 1–3 after GI signs, or up to months later)

• Myoclonus — rhythmic, repetitive muscle twitching (pathognomonic for distemper; also called "chorea")
• "Chewing-gum" seizures — jaw snapping, repetitive chewing movements
• Generalized tonic-clonic seizures
• Ataxia (incoordination)
• Paresis or paralysis (mono-, para-, tetra-)
• Hyperesthesia (increased pain sensitivity)
• Head tilt, circling, compulsive pacing
• Head pressing
• Blindness
• Behavioral changes
• Altered consciousness

Myoclonus (muscle twitch) is the most characteristic neurological sign — it persists even during sleep and is almost pathognomonic for CDV.

Dermatological Signs

• Hardpad disease (hyperkeratosis): thickening and hardening of the nose and footpads — classic lesion, gives the disease its old name "Hardpad Disease"
• Pustular dermatitis: small vesicles/pustules on the abdomen and inner thighs
• Footpad hyperkeratosis — rough, crusty, hard paw pads

Dental Enamel Hypoplasia

• CDV infects ameloblasts (enamel-forming cells) in young puppies before permanent teeth erupt
• Results in pitting, irregular enamel on permanent teeth
• This is a permanent lifelong marker of CDV infection in puppies

---

SECTION 8: SPECIAL FORMS OF DISTEMPER

8.1 Peracute / Fulminating Form

• Seen in very young puppies with no maternal immunity
• Sudden onset, rapid death within days
• Often no characteristic signs before death

8.2 Acute Form

• Classic multi-system disease described above
• Most commonly seen form

8.3 Chronic / Nervous Form

• Predominantly neurological signs
• May occur weeks to months after apparent recovery from acute form
• Progressive demyelination continues

8.4 Old Dog Encephalitis (ODE)

• Very rare
• Affects middle-aged to older dogs (6–8 years+)
• Progressive, non-inflammatory encephalitis
• Characterized by: lack of coordination, compulsive movements, head pressing, visual deficits
• No fever, no active viral shedding
• Thought to be due to viral persistence in CNS

8.5 Post-Vaccinal Distemper Encephalitis

• Extremely rare complication of modified-live virus (MLV) vaccine in very young or immunocompromised puppies
• Presents 1–3 weeks after vaccination
• Virus in the vaccine can occasionally cause CNS signs in puppies vaccinated under 4 weeks of age

---

SECTION 9: DIAGNOSIS

9.1 Clinical Diagnosis (History + Physical Exam)

• Young, unvaccinated dog
• Multi-system disease: respiratory + GI + neurological signs
• Hardpad, myoclonus, mucopurulent discharge = high suspicion
• Biphasic fever

9.2 Hematology / CBC (Blood Test)

• Lymphopenia — key finding, especially in early disease
• Leukopenia (low white blood cells overall)
• Thrombocytopenia (sometimes)
• Non-specific — but lymphopenia in an unvaccinated puppy with respiratory signs is suggestive

9.3 Inclusion Body Detection (Cytology)

• CDV forms intracytoplasmic AND intranuclear inclusion bodies in infected cells
• Called Lentz inclusion bodies
• Found in: erythrocytes (red blood cells), lymphocytes, epithelial cells
• Best smears to examine: Conjunctival smear, buffy coat smear, nasal swab smear
• Stain with Diff-Quik or Giemsa
• Inclusion bodies are eosinophilic (pink), round, found in cytoplasm and nucleus
• Important: Only present early in infection (within first 3 weeks) — disappear as immune response develops
• Sensitivity is low (~30–50%), but highly specific when found

9.4 Immunofluorescence Antibody Test (IFA/FAT)

• Detects CDV antigen in cells using fluorescent-labeled antibodies
• Specimens: conjunctival smears, nasal swabs, buffy coat, CSF cells, footpad biopsy
• Rapid (results in 24–48 hours)
• Sensitivity limited — detects antigen only within first 3 weeks when virus is in epithelial cells
• Post-mortem: Brain, lung, stomach, spleen, lymph nodes — excellent material

9.5 RT-PCR (Reverse Transcriptase PCR) — Gold Standard

• Most sensitive and specific antemortem test available
• Detects CDV RNA
• Specimens: Conjunctival swab, nasal swab, CSF, urine, blood (EDTA), lymphoid tissue, brain
• For neurological cases: CSF is the preferred sample
• For respiratory/GI cases: nasal/conjunctival swabs in viral transport medium
• Important caveat: Can detect vaccine virus in recently vaccinated dogs (within 3–4 weeks of MLV vaccination) — report this to the lab
• RT-qPCR (quantitative) is now the preferred method — rapid, sensitive, can distinguish field virus from vaccine strains in some labs

9.6 Virus Isolation

• Gold standard historically but slow (weeks) and requires BSL-2 facilities
• Not practical for routine diagnosis
• Virus can be isolated from nasal secretions, conjunctival swabs, urine, CSF, blood

9.7 Serology (Antibody Testing)

• Measures antibody response to CDV
• Not useful for acute diagnosis — a single titer cannot differentiate:
  • Vaccinated dogs
  • Recovered dogs
  • Currently infected dogs
• Paired samples (acute + convalescent 2–3 weeks apart): a 4-fold rise in titer is diagnostic
• Useful for: Checking vaccination status, population immunity surveys
• CSF serology: Antibodies in CSF with a higher titer than serum = CDV encephalitis (intrathecal antibody production)

9.8 Histopathology (Post-mortem)

• Key findings:
  • Eosinophilic intranuclear and intracytoplasmic inclusion bodies (Lentz bodies) in neurons, glial cells, epithelial cells
  • Demyelination of white matter (CNS)
  • Perivascular cuffing (lymphocytes around blood vessels in brain)
  • Non-suppurative encephalitis
  • Bronchopneumonia (interstitial pattern)
  • Lymphoid depletion in spleen and lymph nodes

9.9 Immunohistochemistry (IHC)

• Detects CDV antigen in formalin-fixed paraffin-embedded (FFPE) tissue sections
• Very specific and useful for post-mortem confirmation
• Can be done on archived tissues weeks or months later

9.10 CSF Analysis (for Neurological Cases)

• Mild mononuclear pleocytosis (increased lymphocytes)
• Mildly elevated protein
• CDV-specific antibodies may be detected
• RT-PCR on CSF — most sensitive for CNS distemper

---

SECTION 10: DIFFERENTIAL DIAGNOSES

---

SECTION 11: TREATMENT

CRITICAL FACT: There is NO specific antiviral drug approved to directly kill CDV. All treatment is supportive and symptomatic.

11.1 General Principle

11.2 Supportive Care

• IV crystalloids (Lactated Ringer's, Normal Saline) for dehydration
• Correct electrolyte imbalances (especially in dogs with heavy vomiting/diarrhea)

• High-quality, easily digestible food
• Nasogastric/esophageal tube feeding if anorexic
• Maintain body weight — critical for immune function

• Antipyretics for high fever (e.g., Dipyrone/Metamizole in dogs — NOT aspirin/NSAIDs in most cases)

11.3 Antibiotics (For Secondary Bacterial Infections)

• CDV causes immunosuppression → secondary bacterial pneumonia, GI infections
• Broad-spectrum antibiotics:
  • Amoxicillin-clavulanate (first choice for respiratory)
  • Enrofloxacin (for resistant cases — avoid in young dogs, causes cartilage damage)
  • Trimethoprim-sulfamethoxazole (TMP-SMZ)
  • Ampicillin IV in hospitalized dogs
• Choose based on culture/sensitivity when available

11.4 Neurological Management

• Anticonvulsants for seizures:
  • Phenobarbital — first choice for seizure control in CDV
  • Potassium bromide — adjunct
  • Diazepam (IV) for status epilepticus / acute seizure control
  • Levetiracetam — newer option, fewer side effects, good for dogs
• Myoclonus treatment:
  • Difficult to treat; procainamide has been used with limited success
  • Diazepam may reduce intensity
  • Often persists even after recovery

11.5 Ocular Treatment

• Artificial tears / lubricating eye drops for KCS (keratoconjunctivitis sicca)
• Topical antibiotics (chloramphenicol, gentamicin drops) for secondary bacterial conjunctivitis
• Cyclosporine ophthalmic if KCS persists — stimulates tear production

11.6 Respiratory Support

• Mucolytics/expectorants (N-acetylcysteine, bromhexine) for thick secretions
• Nebulization/coupage — helps clear airway secretions
• Oxygen supplementation for severe pneumonia
• Bronchodilators (aminophylline, theophylline) if bronchospasm

11.7 GI Support

• Antiemetics: Maropitant (Cerenia) — best choice; Metoclopramide
• GI protectants: Omeprazole, sucralfate
• Withhold food 12–24 hours then introduce bland diet gradually

11.8 Vitamins & Immune Support

• Vitamin A, C, E — important for epithelial repair and immune function
• Vitamin B complex — neurological support
• Some protocols include ribavirin (antiviral) — experimental, not standard of care

11.9 Investigational / Experimental Treatments

• Ribavirin — some studies show activity against CDV in vitro but clinical use is limited
• Human intravenous immunoglobulin (IVIG) — used in some severe cases
• Interferon-omega (feline interferon) — has been used in some European countries; reduces viral load and improves survival in some studies
• Stem cell therapy — experimental

11.10 Isolation Protocol

• Strict isolation from other dogs — CDV is highly contagious
• Isolate for at least 60–90 days after clinical recovery (viral shedding)
• Disinfect all surfaces, bowls, bedding with dilute bleach (1:30) or quaternary ammonium compounds

---

SECTION 12: PROGNOSIS

• Dogs without neurological signs: 50–70% may recover with intensive care
• Dogs with neurological signs: prognosis is guarded to poor; less than 30% recover without permanent deficits
• Myoclonus if present often persists for life even after recovery
• Dogs that recover from distemper are likely immune for life (long-lasting humoral + cellular immunity)
• Some dogs develop late-onset neurological signs weeks to months after apparent recovery ("post-distemper syndrome")

---

SECTION 13: VACCINATION — Prevention

13.1 CDV Vaccine is a CORE Vaccine

• Recommended by AAHA, WSAVA for all dogs worldwide
• Core vaccines = should be given to every dog regardless of lifestyle

13.2 Types of CDV Vaccines

13.3 Vaccination Schedule (Puppies)

Why multiple puppy doses? Maternally-Derived Antibodies (MDA) from the mother's colostrum neutralize the vaccine virus — the puppy cannot respond until MDA levels drop. Since MDA levels vary between puppies, the series at 3–4 week intervals ensures that at least one vaccine "takes" when MDA is low enough.

Recombinant vaccine can immunize puppies 2 weeks earlier than conventional MLV because it is not a live virus and is less inhibited by MDA. (AAHA 2022 guidelines)

13.4 Duration of Immunity (DOI)

• After a complete puppy series + 1-year booster: immunity lasts at least 3 years, often 5–7+ years or even lifetime
• AAHA recommends 3-year booster intervals for adult dogs after initial series

13.5 Maternal Antibody Interference

• MDA typically wane by 12–14 weeks in most puppies
• MDA can block vaccine until as late as 16 weeks in some puppies
• Vaccination window of susceptibility (WOS): The period when MDA are too low to protect but high enough to block vaccine → puppy is vulnerable
• The 3-dose puppy series closes this window

---

SECTION 14: BIOSECURITY & DISINFECTION

• Disinfectants effective against CDV:
  • 1:30 dilution of household bleach (sodium hypochlorite)
  • Quaternary ammonium compounds
  • Accelerated hydrogen peroxide (Rescue/Accel)
  • Phenolic disinfectants
  • Potassium peroxymonosulfate (Virkon)
• CDV is killed by: Heat, UV light, drying, lipid solvents
• CDV is resistant to: Cold temperatures — survives freeze-thaw cycles
• In shelter/kennel settings: disinfect all surfaces, food bowls, bedding, hands, equipment between animals
• Isolate suspected cases immediately
• Do NOT share equipment between infected and healthy animals

---

SECTION 15: CDV IN WILDLIFE — Zoonotic Concern?

• CDV is NOT zoonotic — does not infect humans
• However, wildlife serves as a reservoir — raccoons, foxes, coyotes, skunks can spread CDV to domestic dogs
• CDV has caused mass mortality events in:
  • African lions (Serengeti, 1994)
  • Caspian seals
  • Amur tigers
  • Iberian wolves
• CDV is the #2 infectious disease threat to wild carnivore conservation (after rabies)
• Vaccination of domestic dogs = best strategy to reduce wildlife spill-over

---

SECTION 16: CDV & MEASLES — Historical Connection

• CDV and measles virus are genetically ~70% similar
• CDV origin: likely mutated from human measles virus or a common ancestor, possibly introduced to dogs from humans (or vice versa) centuries ago
• CDV cannot infect humans today, but measles vaccine provides cross-protection against CDV in puppies
• Measles vaccine was historically used to immunize young puppies against distemper (it bypasses MDA) — now replaced by recombinant CDV vaccine

---

SECTION 17: SUMMARY DIAGNOSTIC ALGORITHM

Unvaccinated puppy/dog
        ↓
Fever + leukopenia (Day 3-6)
        ↓
Mucopurulent discharge (eyes + nose)
        ↓
Respiratory + GI signs
        ↓
Neurological signs (myoclonus, seizures)
        ↓
± Hardpad (nose/paw pad hyperkeratosis)

DIAGNOSIS TOOLS:
→ CBC: lymphopenia
→ Conjunctival smear: inclusion bodies (early only)
→ RT-PCR: nasal swab / CSF (most sensitive)
→ IFA: conjunctival/nasal smear
→ Post-mortem: histopathology + IHC

---

SECTION 18: COMMONLY ASKED QUESTIONS (Q&A)

---

---

---

---

---

---

---

---

---

1. Vaccinate — complete the full puppy series (at 6–8, 10–12, and 14–16 weeks) + 1-year booster + 3-yearly adult boosters
2. Avoid contact with unvaccinated or stray dogs, especially in high-risk areas (shelters, dog parks)
3. Keep wildlife away from your dog — raccoons, foxes, and skunks carry CDV
4. Quarantine any new dog for 14 days before introducing to existing dogs
5. Disinfect properly in multi-dog environments

---

• Lifelong myoclonus (muscle twitching)
• Enamel hypoplasia on permanent teeth (if infected as puppy)
• Keratoconjunctivitis sicca (dry eye — requires lifelong treatment)
• Residual neurological deficits (ataxia, weakness)
• Late-onset encephalitis (old dog encephalitis)

---

---

---

---

If rabies cannot be ruled out clinically, treat with full precautions and report to authorities.

---

• Canine Distemper — Merck Veterinary Manual
• Canine Distemper — Veterian Key (Greene's Infectious Diseases of the Dog and Cat)
• CDV — Cornell University College of Veterinary Medicine
• AAHA Canine Vaccination Guidelines 2022 — CDV
• Rivera-Martínez A et al. Canine Distemper Virus: Origins, Mutations, Diagnosis, and Epidemiology. Life (Basel). 2024. PMID: 39202744
• Wilkes RP. CDV in Endangered Species. Pathogens. 2022. PMID: 36678405
• Rendon-Marin S et al. Safety and Immunogenicity of Morbillivirus canis Vaccines. Viruses. 2024. PMID: 39066240

---

---

📋 Quick Reference — What Was Covered:

---

📋 What Was Covered — Section Summary:

---

📋 What Was Covered:

---

📋 Complete Coverage Summary:

---

📋 Complete Coverage Summary:

---

What This Guide Covers (Quick Index)

---

Quick Index — What This Guide Covers

---

Quick Index — What This Guide Covers

---

What This Guide Covers

• USMI (most common in adult dogs) — pathogenesis in full (estrogen loss + intrapelvic bladder neck), all breeds, PPA + estriol + DES doses, colposuspension, collagen injections, artificial sphincter
• Ectopic ureter (most common juvenile dogs) — intramural vs extramural, CT urography then cystoscopy workflow, laser ablation + neoureterocystostomy, why 50% remain incontinent post-surgery
• Neurogenic (UMN vs LMN) — clinical differentiation, drug protocols (prazosin/phenoxybenzamine for UMN; bethanechol for LMN; diazepam/dantrolene for external sphincter), manual expression guidelines
• Detrusor instability — oxybutynin mechanism + dosing
• Overflow/paradoxical — recognize and relieve obstruction
• Behavioral, polyuric-associated, post-obstructive

• Laila (4yr spayed Doberman — classic USMI) — complete diagnostic workup, PPA dosing, combination therapy, skin care
• Simba (5-month intact Labrador — right intramural ectopic ureter + secondary UTI) — CT urography findings, cystoscopic laser ablation plan, 3-phase management